Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Capital Expenditures (2024)

Pyxis Oncology (PYXS) has disclosed Capital Expenditures for 1 consecutive years, with $237000.0 as the latest value for Q1 2024.

  • Quarterly Capital Expenditures changed N/A to $237000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $237000.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $9000.0 for FY2025, 96.2% down from the prior year.
  • Capital Expenditures for Q1 2024 was $237000.0 at Pyxis Oncology.
  • The five-year high for Capital Expenditures was $237000.0 in Q1 2024, with the low at $237000.0 in Q1 2024.